Latest Whitepapers

Neutralizing antibodies are currently being investigated as one such strategy against SARS-CoV-2, as they have the potential to block the virus from infecting host cells. Download this whitepaper to learn more about the antiviral mechanism of SARS-CoV-2 neutralizing antibodies and global efforts to develop neutralizing antibody products against the virus.

Download this whitepaper to understand more about how automated sample storage can aid in the research of COVID-19.

Life science R&D is developing incredible solutions to global problems. But this ground breaking work is often being done with outdated tools that weren't designed with the complexity of life science in mind. Let's explore the core questions that R&D organizations are struggling to answer.

Access this whitepaper to discover how the analytical techniques that can facilitate research, development and quality control during drug development.

R&D organizations are only as good as their data and the insights their teams can derive from it. This whitepaper highlights the steps you can take to improve the data culture at your company.

Assurance of data integrity is increasingly difficult for bioanalytical laboratories. This whitepaper discusses the issues of and procedures for maintaining data integrity.

This document describes how Malvern Panalytical systems support system owners, meeting the requirements of the 21 CFR Part 11 regulations issued by the United States’ FDA.

Download this white paper to learn all about hybridoma-based antibody development, including their key benefits and misconceptions.

Download this white paper to understand how PerkinElmer’s Lead Discovery Premium can help deliver unified, interactive, responsive, data-agnostic access to all users.

This white paper will give you advice on how to save time, money, reduce risk and future-proof your bioband business.